Cellectricon strengthens its expertise in neurodegenerative diseases by the appointment of new Scientific Advisory Board member Professor Henrik Zetterberg

/in , /by

Cellectricon, a collaborative services provider dedicated to advance drug discovery and research in the areas of chronic pain and CNS disease, has appointed Professor Henrik Zetterberg to its scientific advisory board. Professor Zetterberg brings extensive expertise in Alzheimer’s disease and other neurodegenerative brain disorders. Professor Zetterberg, MD, PhD, is Professor of Neurochemistry at the University […]

Read more →

TA Instruments names Dr. Rossana Pasquino as a “Distinguished Young Rheologist”

/in , /by

New Castle, Delaware, USA. – TA Instruments is pleased to announce the latest recipient of the Distinguished Young Rheologist award: Dr. Rossana Pasquino, Associate Professor at the University of Naples Fredrico II. Dr. Pasquino is recognized for her work in the rheology of complex fluids, using it as a tool to detect morphology and microscopic properties. […]

Read more →

Genovis further expands marketing organization

/in , , , /by

Genovis is expanding its sales and marketing organization at its Lund headquarters and has hired Rob Horsefield as Sales & Business Development Manager. Rob has multiple years of experience in the industry from sales in analytical chemistry, pharmaceutical development and protein chemistry. Rob will join Genovis in August. Rob Horsefield holds a PhD in protein […]

Read more →

Life Sciences Industry Veteran Todd R. Nelson Named SGI-DNA CEO to Lead Spin-out from Synthetic Genomics

/in , /by

SAN DIEGO — SGI-DNA, a leader in commercial DNA synthesis, today announced industry veteran Todd R. Nelson, Ph.D., MBA has been appointed Chief Executive Officer to lead the spin-out of the company from Synthetic Genomics, Inc. (SGI). “Todd is a proven life sciences leader who brings a wealth of knowledge and experience to commercial organizations like SGI-DNA with disruptive […]

Read more →

New board members bolstering expansion into diagnostics market

/in , /by

Symcel appoints two new board members to bolster R&D business growth and expansion into the clinical diagnostics market   L: Stefan Löfås, R: Erik Walldén  Symcel – the company behind the revolutionary cell-based assay tool for real-time cell metabolism measurements, the calScreener™ – has announced the appointment of two new highly experienced board members; Erik Walldén and […]

Read more →

Laurent Dumas Joins TESCAN USA Team

/in /by

TESCAN is pleased to announce the recent hiring of Laurent Dumas, M.C. for the position of Application Manager in TESCAN USA. Mr. Dumas is responsible for overseeing a team of applications specialists, managing a collection of FIB and SEM workstations, organizing product demonstrations and sample evaluations and ensure the laboratories are maintained at the highest […]

Read more →

David King Joins Fluidigm as Vice President, Research and Development, Genomics

/in /by

SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (NASDAQ:FLDM) today announced the appointment of David King as Vice President, Research and Development, Genomics. As a member of the executive leadership team reporting to President and CEO Chris Linthwaite, King will drive R&D strategy and execution for all genomics products and systems across the company. “Fluidigm is a leader in deep, high-parameter […]

Read more →

NanoCellect Biomedical Names New CEO

/in /by

San Diego, Calif. – NanoCellect Biomedical Inc., a leader in the development and manufacture of innovative tools for cell analysis and sorting, today announced that Chris Neary has joined the company’s management team as CEO.  The appointment is part of NanoCellect’s expansion following its successful introduction of the unique Wolf® Cell Sorter system.  Neary will […]

Read more →